Mirator 0.125 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Pramipexole (0.125mg)
Overview Mirator 0.125 Tablet
Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move legs due to unpleasant sensations) are treated with Mirator 0.125mg tablets. These tablets mitigate excessive tremors by reducing motor activity. Administer Mirator 0.125mg tablets with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement; never discontinue abruptly without consulting your doctor. Common adverse effects may include nausea, dry mouth, tiredness, visual disturbances, bowel irregularity, and swelling in the extremities. Drowsiness and dizziness are also possible; avoid driving or tasks requiring alertness until the medication's effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor, as these can be serious.
Uses of Mirator 0.125 Tablet
Parkinson's disease and restless legs syndrome
Major Benefits of Mirator 0.125 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Mirator 0.125 mg Tablet with a meal.
Common Side effects of Mirator 0.125 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Mirator 0.125 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mirator 0.125mg Tablet should be administered with a meal.
How Mirator 0.125 Tablet works:
Mirator 0.125 mg tablets function by imitating dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Mirator 0.125 mg tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Mirator 0.125mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Using Mirator 0.125 Tablet while breastfeeding is likely unsafe. Available evidence indicates potential transfer to breast milk, posing a risk to the infant. This medication lowers prolactin levels, potentially disrupting lactation.
DrivingUNSAFE
Driving ability may be impaired by Mirator 0.125 Tablet, which can induce side effects including hallucinations (perceptual distortions of sight, sound, or touch).
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mirator 0.125mg tablets. Dosage modification for Mirator 0.125mg tablets may be necessary; physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mirator 0.125mg tablets in patients with hepatic impairment is likely safe. Available evidence indicates that dosage modification may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Mirator 0.125 Tablet :
Omit any missed Mirator 0.125 Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirator 0.125 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzothiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Dopamine-stimulating medications |
3,018 People bought this recently